Oncopharmpod
Early July FDA Updates
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:13:29
- More information
Informações:
Synopsis
FDA ended June with 5 new approvals. *selinexor for r/r DLBCL *pembrolizumab for cutaneous squamous cell carcinoma *pembrolizumab for MSI-h/dMMR met. colorectal cancer *avelumab maintenance for met. bladder cancer *SC trastuzumab/pertuzumab/hyaluronidase
